Durham start­up rais­es Se­ries A to tack­le un­drug­gable pro­teins, in­clud­ing can­cer bad­die Myc, with gen­er­a­tive AI

The num­ber of ways atoms can be arranged to cre­ate po­ten­tial drugs is so large — 1063, by one es­ti­mate — that it ex­ceeds the num­ber of stars in the uni­verse. It’s a num­ber too vast for sci­en­tists to ever search through, at least on their own.

But a small start­up spun out of Duke Uni­ver­si­ty hopes that a lit­tle help from AI could change that.

Ten63 Ther­a­peu­tics raised $15.9 mil­lion in Se­ries A fi­nanc­ing led by Hat­teras Ven­ture Part­ners, the start­up an­nounced Tues­day. Co-founder and CEO Mar­cel Frenkel told End­points News that his com­pa­ny will ex­plore pos­si­ble struc­tures for small mol­e­cule drugs “at a scale that has nev­er been done be­fore.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER